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HIV infection leads to a phenomenon of inflammaging, in which chronic inflammation
induces an immune aged phenotype, even in individuals on combined antiretroviral
therapy (cART) with undetectable viremia. In this study, we investigated T cell
homeostasis and telomeric DNA damage and repair machineries in cART-controlled
HIV patients at risk for inflammaging. We found a significant depletion of CD4 T cells,
which was inversely correlated with the cell apoptosis in virus-suppressed HIV subjects
compared to age-matched healthy subjects (HS). In addition, HIV CD4 T cells were prone
to DNA damage that extended to chromosome ends—telomeres, leading to accelerated
telomere erosion—a hallmark of cell senescence. Mechanistically, the DNA double-strand
break (DSB) sensors MRE11, RAD50, and NBS1 (MRN complex) remained intact, but
both expression and activity of the DNA damage checkpoint kinase ataxia-telangiectasia
mutated (ATM) and its downstream checkpoint kinase 2 (CHK2) were significantly
suppressed in HIV CD4 T cells. Consistently, ATM/CHK2 activation, DNA repair, and
cellular functions were also impaired in healthy CD4 T cells following ATM knockdown
or exposure to the ATM inhibitor KU60019 in vitro, recapitulating the biological effects
observed in HIV-derived CD4 T cells in vivo. Importantly, ectopic expression of ATM was
essential and sufficient to reduce the DNA damage, apoptosis, and cellular dysfunction
in HIV-derived CD4 T cells. These results demonstrate that failure of DSB repair due
to ATM deficiency leads to increased DNA damage and renders CD4 T cells prone to
senescence and apoptotic death, contributing to CD4 T cell depletion or dysfunction in
cART-controlled, latent HIV infection.
Keywords: ATM, apoptosis, DNA damage repair, immune aging, HIV, T cell homeostasis
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INTRODUCTION

before entering cell cycle arrest, senescence, or apoptosis (21, 22).
However, telomere loss can increase up to 250 bp per cell division
during viral infection, and in compensating for this, cell cycle
arrest occurs when progressive telomere loss reaches a critical
point—known as senescence (a quiescent, non-replicative state
with a decline in functional activities) (21, 22). Thus far, the
precise mechanisms controlling telomeric DNA damage, T cell
homeostasis, inflammaging, and immune senescence in latent
HIV infection remain unclear.
In this study, we investigated the molecular mechanisms
that perturb T cell homeostasis and lead to inflammaging
using a model of HIV-infected individuals on cART with
undetectable viremia—the state in which the majority of HIV
patients currently exist. We demonstrate that deficiency of ataxiatelangiectasia mutated (ATM) kinase promotes DNA damage,
telomere erosion, and T cell senescence and apoptosis in
latent HIV infection. Specifically, we show that cART-controlled
HIV infection is characterized by telomeric DNA damage that
remains unrepaired due to ATM deficiency, leading to telomere
attrition and CD4 T cell senescence or apoptosis, providing a
novel mechanism controling T cell homeostasis and premature
immune aging. Thus, restoring impaired ATM machinery may
provide a new strategy to improve T cell survival and functions
in cART-controlled HIV infection.

Aging is associated with, and may be caused by, lowgrade inflammation—a phenomenon known as inflammaging.
Inflammaging is a major driver of age-related phenomena such
as increased susceptibility to infections, reduced responses to
vaccines, and increased incidence of cancers, cardiovascular
diseases, and neurodegeneration, all of which contribute to
comorbidity and mortality in the elderly (1–3). In the human
immune system, CD4 T cells are long-lived, and thus are exposed
to extensive genomic insults and replicative pressure, making
them vulnerable to aging-associated abnormalities. Notably,
the progressive loss of T cell proliferative capacity during the
aging process directly correlates with the gradual shortening of
telomeres—a hallmark of cell senescence. Therefore, telomere
length has been deemed as a biological clock controlling cell
aging, survival, and function, whereas telomere attrition has been
considered a faithful readout of inflammaging (1–3).
Growing evidence suggests that this aging phenotype is
recapitulated in chronic viral infections, particularly in human
immunodeficiency virus (HIV) infection, which is characterized
by disrupted CD4 T cell homeostasis and accelerated premature
immune aging (4). Many of the alterations that affect the
immune system in HIV-infected individuals are reminiscent of
the progression of inflammaging in the elderly (5, 6). Currently,
combined antiretroviral therapy (cART) does not always result in
complete CD4 T cell recovery (7–10). Despite successful control
of HIV replication by cART, residual inflammaging persists,
leading to significant immune dysfunction. Even with reasonable
CD4 T cell counts, these cART-controlled HIV patients often
experience profound inflammaging, characterized by extremely
short telomeres, low IL-2 production, poor cellular proliferation,
and blunted vaccine responses (5–16). This exposes the immune
system to unique challenges that lead to T cell exhaustion
and senescence, similar to that observed in the elderly. These
alterations accelerate the decline of CD4 T cell competence and
thus define the overall immune dysfunction during HIV latency.
Therefore, cART-controlled, latent HIV infection can be deemed
as an excellent model of inflammaging in humans; as such, it
is very important to elucidate the mechanisms underlying T
cell senescence, telomere erosion, and inflammaging in latent
HIV infection.
Because telomeric DNA damage can cause telomere erosion,
leading to premature cell aging and/or apoptosis (17, 18), we
hypothesized that progressive CD4 T cell loss and failure of
immune recovery during latent HIV infection could be, at least
in part, due to a deficiency in the DNA repair mechanism
that alters telomere integrity. Indeed, we have previously shown
that patients with chronic hepatitis C virus (HCV) infection
exhibit premature T cell aging, evidenced by overexpressed
aging markers and particularly, shortened telomeres—indicative
of excessive proliferative turnover or inadequate telomeric
maintenance (19, 20). Notably, in normal primary T cells,
telomeres undergo shortening at a rate of 50–100 base pairs (bp)
per cell division, and this predictable loss of telomeric DNA
with cell replication allows telomeres to serve as a molecular
clock that controls the replicative capacity of human T cells
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RESULTS
CD4 T Cell Homeostasis and Apoptotic
Susceptibility in cART-Controlled, Latent
HIV Infection
Dysregulated T cell homeostasis is a characteristic of chronic viral
infections (23); however, the precise mechanisms that control T
cell homeostasis and virus persistence in humans remain unclear.
As an initial approach to identify factors that perturb T cell
homeostasis in latent HIV infection, we analyzed total (CD4+ ),
naïve (CD4+ CD45RA+ ), and memory (CD4+ CD45RA− ) T
helper cell frequencies within peripheral blood mononuclear
cells (PBMCs) isolated from HIV-infected individuals on cART
with undetectable viremia or age-matched healthy subjects
(HS). As shown in Figure 1A (representative pseudocolor plots
and summary data of flow cytometry), the numbers of total
CD4 T cells, naïve CD4, especially memory CD4 T cell pools,
were significantly contracted in latently HIV-infected individuals
compared to HS. To determine which subsets of CD4 T cells were
most affected in latent HIV infection, we analyzed samples for
their naïve CD4 (TN , CD4+ CD45RA+ CCR7+ ), central memory
CD4 (TCM , CD4+ CD45RA− CCR7+ ), effector memory CD4
(TEM , CD4+ CD45RA− CCR7− ), and terminal effector CD4 T
cells (TTE , CD4+ CD45RA+ CCR7− ) in this cohort. We found
that TCM was the primarily contracted subset in PBMCs during
HIV latency (Figure 1B). We also analyzed the frequencies of
these subsets in the total CD4 T cell populations from the same
subjects, and observed contraction in TCM, but expansion in
the other subsets of CD4 T cells during latent HIV infection
(Figure 1C). This contraction of total CD4 T cells, particularly
the TCM subset, is consistent with published reports (24, 25)

2

November 2019 | Volume 10 | Article 2531

Zhao et al.

ATM in HIV T Cells

FIGURE 1 | T cell homeostasis and apoptosis in HIV-infected patients vs. age-matched HS. (A) PBMCs were isolated from 24 HIV-infected patients and 27 HS and
analyzed for T cell homeostasis by flow cytometry. Representative pseudocolor plots and summary data for total CD4+ , CD45RA+ CD4+ (naïve), and CD45RA− CD4+
(memory) T cell frequencies are shown. Each symbol represents an individual subject. The mean ± SEM or median ± interquartile range and p-value are shown. (B)
Flow cytometry was used to analyze the the frequencies of total CD4+ , CD4+ CD45RA+ CCR7+ TN , CD4+ CD45RA− CCR7+ TCM , CD4+ CD45RA− CCR7− TEM , and
CD4+ CD45RA+ CCR7− TTE cells in PBMCs from 4 HIV patients and 4 HS. (C) The percentages of each CD4 T cell subset within the total CD4+ lymphocyte
populations in 4 HIV patients vs. 4 HS are shown. (D) PBMCs isolated from 31 HIV-infected patients and 17 HS were analyzed for T cell apoptosis by flow cytometry.
Representative pseudocolor plots and summary data for the Av staining in total CD4+ , CD45RA+ CD4+ (naïve), and CD45RA− CD4+ (memory) T cells are shown.
Each symbol represents an individual subject. The mean ± SEM and p-value are shown. Outliers in HIV groups were removed during statistical analysis. (E) Pearson’s
correlation analysis between total or memory CD4 T cell frequencies and early apoptotic cells in PBMCs isolated from HIV subjects. (F) Pearson’s correlation analysis
between CD4 T cell frequencies and actual CD4 T cell counts in HIV subjects.

(Figure 1E), as analyzed by Pearson correlation. Also, the flow
cytometry analysis of CD4 T cell frequencies faithfully correlated
with the actual count of CD4 T cell numbers (Figure 1F),
suggesting that CD4 T cell apoptosis closely correlates with
CD4 T cell loss during latent HIV infection. These results
indicate that the apoptotic susceptibility of CD4 T cells during
latent HIV infection may necessitate compensatory homeostatic
proliferation, leading to CD4 T cell exhaustion and senescence.

and indicates an alteration of T cell repertoire following cell
activation, exhaustion, senescence, and apoptosis in cARTcontrolled, latent HIV infection.
The T cell repertoire in peripheral blood is well-maintained
by a fine balance between an influx of newly generated T
cells from the thymus, efflux by consumption via programmed
cell death, and self-replication within the existing pool of
lymphocytes. With deficient influx from the thymus in adults,
the immune system responds to challenges by expanding existing
T cells, leading to increased proliferative turnover, telomere
erosion, and ultimately, cell apoptosis, which represents a major
mechanism for controlling peripheral T cell homeostasis in
adults (26). To explore how apoptosis contributes to T cell
homeostasis in HIV latency, we compared the Annexin V (Av)
and 7-Aminoactinomycin D (7AAD) staining in PBMCs derived
from latently HIV-infected individuals and age-matched HS.
As shown in Figure 1D (representative pseudocolor plots and
summary data of flow cytometry), Av staining of CD4 T cells
showed increases in apoptotic cells in latently HIV-infected
individuals within the total CD4, as well as in naïve CD4 and,
particularly, memory CD4 T cells. Importantly, apoptosis of HIV
CD4 T cells, especially CD4+ CD45RA− memory CD4 T cells,
appeared to be negatively correlated with their cell frequencies

Frontiers in Immunology | www.frontiersin.org

CD4 T Cell Exhaustion and Senescence in
cART-Controlled, Virus-Suppressed HIV
Infection
To determine the role of homeostatic proliferation in T cell
exhaustion and senescence, we first compared relevant markers
expressed on CD4 T cells isolated from latently HIV-infected
individuals vs. age-matched HS. As shown in Figure 2A, the
expression of programmed death-1 (PD-1), a marker for cell
exhaustion, was significantly upregulated in lymphocytes, as well
as in CD4 T cells, in cART-controlled HIV patients compared to
age-matched HS.
Since the loss of CD28, a T cell receptor (TCR) costimulatory molecule required for T cell activation and survival,
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FIGURE 2 | CD4 T cell exhaustion and senescence and telomere attrition in latent HIV infection. (A) Percentage of PD-1 expression on total lymphocytes and CD4 T
cells in PBMCs isolated from 10 HIV patients vs. 10 HS, as determined by flow cytometry. (B) Percentage of CD28− population in CD4 T cells from 23 HIV patients vs.
31 HS. (C) Percentage of CD57 expression on CD4 T cells from 8 HIV patients vs. 10 HS. (D) Representative dot plots, histogram, and summary data from 24 HIV
patients and 24 HS from Flow-FISH analysis of telomere length in total, naïve, and memory CD4 T cells. (E) Spearman’s correlation analysis of naïve and memory
CD4 T cell telomere length (MFI) and the percentage of Av+ apoptotic cells in 8 HIV patients and 8 HS are shown.

by measuring telomere length in total CD4+ , CD4+ CD45RA+
naïve, and CD4+ CD45RA− memory CD4 T cells by FlowFISH. As shown in Figure 2D (representative plots for gating
strategy and pooled data of flow cytometry), telomere length
was significantly shortened in HIV-derived, total CD4 T cells,
and particularly in memory CD4 T cells, compared to agematched HS. Since telomere length is critical for cell survival, we
hypothesized that longer telomeres in HS will secure cell survival,
whereas shorter telomeres in HIV subjects may promote cell
apoptosis. To test this hypothesis, we analyzed the relationship
between cell apoptosis and telomere length in both HIV
subjects and HS. Importantly, telomere length appeared to be
inversely correlated with the cell apoptotic rate in naïve and
memory CD4 T cells from HIV subjects and HS, as determined
by Spearman correlation (Figure 2E), indicating that telomere
erosion is associated with T cell apoptosis.
Since HIV replication is well-controlled by cART in our
cohort, an important question remains: what drives telomere
erosion and T cell apoptosis during latent HIV infection? We
and others have previously shown that naïve CD4 T cells are
typically resistant to death receptor/ligand (Fas/Fas-L)-mediated
apoptosis (19, 20, 29–31). Indeed, resting CD4 T cells typically do
not express Fas on their cell surface, and blocking the exogenous
death pathways such as Fas-Fas ligand, TNFα-TNF receptor,
and TRAIL-TRAIL receptor interactions in CD4 T cells did not
affect the KML001 (NaAsO2, an arsenic telomere targeting drug)induced cell apoptosis (31), suggesting intracellular signals as
initiators of apoptosis. Notably, one internal stressor linked to cell
apoptosis is damaged DNA, which is particularly prominent in

is considered as an unequivocal marker of T cell senescence (27),
we determined the CD28− population within the CD4+ T cells.
Similar to a report by the AGEhIV Study Group (9), we also
observed a slight increase of CD28− subset in CD4+ T cells
in latently HIV-infected individuals, although it did not reach
significance when compared to age-matched HS in our cohort
(Figure 2B).
We have previously reported that CD57, also known as human
natural killer 1 (HNK1) that is expressed on the senescent NK or
T lymphocytes (28), is highly expressed on CD4 T cells derived
from chronically HCV-infected individuals (20). We found that
the frequency of CD57+ in CD4+ T cells was significantly
increased in HIV patients vs. HS (Figure 2C). This significant
upregulation of CD57 expression was also observed in CD4 T
cells isolated from HIV and HS that were cultured in vitro for
3 days with or without TCR stimulation (n = 12 per group; p =
0.0003 and p = 0.0002, respectively), suggesting that HIV-derived
CD4 T cells are exhausted and senescent.

CD4 T Cell Telomere Attrition in
Virus-Suppressed, Latent HIV Infection
Telomeres are repeating hexameric sequences of DNA found
at chromosome ends in association with a complex of
shelterin proteins. Telomere integrity is a key feature of linear
chromosomes that preserves genome stability and function,
whereas telomere attrition is a hallmark of cell aging or
senescence that drives cell dysfunction or apoptosis (17, 18).
Given the importance of telomere attrition in cell senescence,
we further investigated aspects of T cell aging in HIV latency

Frontiers in Immunology | www.frontiersin.org
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as a docking site for other mediators, transducers, and DNA
repair proteins to form microscopically visible nuclear foci (DNA
damage foci) (34). Thus, identifying damaged telomere-induced
foci (TIF) is considered as a hallmark of telomeric DNA damage
response (DDR) (35). To determine telomeric DDR in T cells
during latent HIV infection, we compared the number of TIFs
per nucleus, as well as the percentage of cells with ≥3 TIFs,
by examining co-localization of 53BP1 and telomeric repeatbinding factor 1 (TRF1) using confocal microscopy. As shown
in Figure 3D (representative images and summary data), the
number of TIFs per nucleus and the percentage of T cells with
≥3 TIFs were significantly higher in CD4 T cells derived from
HIV patients compared to HS. Moreover, the percentage and
MFI of phosphorylated H2AX (γH2AX), a marker of DNA
damage, were significantly upregulated in total CD4 as well as
in naïve and memory CD4 T cells from HIV patients compared
to HS (Figure 3E). These results suggest that telomeric DNA
damage may cause cell apoptosis and T cell loss in patients with
virus-suppressed, latent HIV infection, emphasizing the role of
telomere integrity in securing T cell survival.

senescent T cells that have been chronically exposed to oxidative
stress, such as endogenously generated ROS (32). To determine
whether ROS might be an offender causing DNA damage and cell
apoptosis during latent HIV infection, CD4 T cells were isolated
from cART-controlled HIV patients and HS, and cultured in
vitro without stimulation for 1–4 days (to generate endogenous
ROS). Levels of ROS were then measured by flow cytometry
using Cellular ROS Detection Kit based on the absorption
of cell-permeable 2′ ,7′ -dichloroflurescein diacetate (DCFDA)—a
fluorogenic dye that measures hydroxyl, peroxyl, and other ROS
activity within the cell (33). As shown in Figure 3A, the median
fluorescence intensity (MFI) of DCFDA was increased in CD4 T
cells derived from cART-controlled HIV patients compared to
age-matched HS. Interestingly, when these cells were cultured in
vitro without stimulation for 1–4 days, the MFI of DCFDAhigh
cells remained high in HIV T cells, whereas the percentage
of DCFDAhigh cells decreased, along with an increase in Av+
apoptotic cells, in HIV vs. HS (data not shown). Similar data were
obtained using a different fluorogenic probe (CellROX Green) to
measure ROS production in cultured CD4 T cells derived from
HIV and HS. As shown in Figure 3B, depending on the levels of
ROS and Av, CD4 T cells from both HIV patients and HS were
gated on two major populations: Av+ ROSlow and Av− ROShigh .
Notably, in both HIV patients and HS, apoptotic (Av+ ) cells
produced lower amount of ROS (MFI ROSlow ) compared with
non-apoptotic (Av− ) cells (MFI ROShigh ). While the MFI of both
Av− ROShigh and Av+ ROSlow subsets remained higher in HIV
than HS, the percentage of Av− ROShigh cells was lower, whereas
the percentage of Av+ ROSlow CD4 T cells was much higher in
HIV patients compared to HS. Likewise, we also examined the
relationship between ROS generation and cell apoptosis in CD8+
T cells and found that the MFI of ROS was significantly increased
and positively correlated with the apoptosis levels in CD8+ T
cells in HIV patients vs. HS (Figure 3C). These data suggest
that the intracellular ROS generated during HIV infection may
play an important role in triggering cell apoptosis and that
the apoptotic cells produce less ROS. Av staining reflects an
inversion of phosphatidylserine at the cell membrane through the
activation of scramblase(s); this can be caused by other stimuli,
such as type I IFN, and as such our findings are also compatible
with an alternative apoptosis-independent interpretation, e.g.,
IFN-induced scramblase activation and anti-oxidative effects on
CD4 T cells during HIV latency.

ATM Expression and Activity Are Inhibited
in CD4 T Cells in Virus-Suppressed, Latent
HIV Infection
Accumulation of damaged DNA in CD4 T cells indicates that the
DNA damage sensing and repairing machineries are impaired
during HIV infection. Essential components of this machinery
include DNA damage sensors, such as the MRE11, RAD50, and
NBS1 (MRN) complex, which recruits and mediates activation of
the DNA damage checkpoint kinase ATM that can phosphorylate
several downstream checkpoint proteins, including checkpoint
kinase 2 (CHK2) and p53 (36–38). To investigate the cellular
machineries that promote DNA damage during HIV infection,
we examined mRNA transcripts and protein expression of these
DDR proteins in CD4 T cells. As shown in Figure 4A, RTqPCR analysis of the MRN complex transcripts showed no
alterations in the level of MRE11, RAD50, or NBS1. In parallel,
the protein levels of these DNA damage sensors in CD4 T
cells remained unchanged in HIV patients and HS (Figure 4B).
Intriguingly, while the mRNA level of ATM was unchanged
(Figure 4C), ATM protein level and, phosphorylation of Ser1981,
an indicator of ATM activity, were inhibited in CD4 T cells
from HIV patients compared to HS (Figure 4D; representative
images and summary data of western blotting). The inhibition
of ATM phosphorylation was confirmed by flow cytometry
in total CD4 as well as in naïve and memory CD4 T cells
from the studied subjects (Figure 4E). Concurrently, while the
mRNA levels of the ATM downstream signaling molecule CHK2
and p53 remained unchanged (Figure 4F), phosphorylation of
CHK2 (pCHK2), measured by flow cytometry, was significantly
inhibited in HIV T cells (Figure 4G). CHK2 inhibition was
also detected by western blot in HIV T cells compared to HS
(Figure 4H). Moreover, in line with the increased DNA damage
and cell apoptosis in HIV T cells, the level of full-length Poly
ADP-Ribose Polymerase 1 (PARP-1) (39) was decreased, whereas
the caspase 3-dependent cleaved PARP-1 was increased in HIV

CD4 T Cell DNA Damage in
cART-Controlled, Virus-Suppressed HIV
Infection
Cells are equipped with DNA damage surveillance and repair
machineries to prevent cell death associated with genomic
instability. Mammalian telomeres consist of triple guanine
repeats (TTAGGG) that are very sensitive to oxidative DNA
damage, and particularly vulnerable to ROS. We hypothesized
that telomere sequences in HIV-derived T cells are not only
shortened, but also DNA damaged. Notably, following genotoxic
insult, p53-binding protein 1 (53BP1) is recruited to the DNA
damage site on chromosomes (including telomeres) and acts
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FIGURE 3 | ROS generation and telomeric DNA damage in CD4 T cells from HIV patients vs. HS. (A) MFI of DCFDA levels in CD4 T cells isolated from PBMCs of 10
HIV patients and 10 HS, and cultured in vitro without stimulation for 1–4 days, then analyzed by flow cytometry. (B) Flow cytometry analysis for the percentage (%)
(Continued)
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FIGURE 3 | and MFI of CellROX Green as well as Av levels in CD4 T cells derived from HIV or HS and cultured ex vivo for 4 days. Representative pseudocolor plots
and summary data of the MFI as well as % of the two gated cell populations (AV− ROXhigh and Av+ ROXlow ) from 3 subjects in each group are shown. (C) MFI of
CellROX Green, cell apoptotic rate, as well as the correlation of ROS production and apoptotic rate in CD8+ T cells in 6 HIV and 6 HS. (D) Confocal microscopy
analysis of 53BP1 and TRF1 co-localization in the nuclei of CD4 T cells isolated from 8 HIV patients vs. 8 HS. Approximately 100 cells were counted per subject.
Summary data of dysfunctional telomere-induced foci (TIF) number per nuclei and the percentage of cells with ≥3 TIFs in the two groups are shown. (E)
Representative plots and summary data of the percentage of γH2AX expression in purified CD4 T cells from 16 HIV patients and 16 HS, as well as the MFI in total,
naïve and memory CD4 T cells in PBMCs from 8 HIV patient vs. 8 HS.

T cells. Taken together, these results indicate that the doublestrand break (DSB) MRN sensing machinery remains intact,
but the protein expression and activation of ATM/CHK2—two
key components critically important for repairing DSB during
DDR—are significantly suppressed at the post-transcriptional
level during latent HIV infection.

lower ATM/pATM and CHK2/pCHK2 expressions, along with
suppression of AKT/pAKT, and an increase in the level of cleaved
PARP-1. These results indicate cross-talk between the ATM and
AKT pathways, and that ATM deficiency is likely induced via
inhibition of the PI3K pathway.

The Non-homologous End Joining (NHEJ)
Pathway Is Involved in ATM-Mediated DNA
Repair and Telomere Maintenance

ATM Protects T Cells From DNA Damage,
Cell Apoptosis, and Dysfunction via the
PI3K Pathway

We next examined the role of ATM in protecting T cells from
DNA damage and found that T cells treated with the ATMi
exhibited an increase in the expression of γH2AX, a marker for
DNA damage (Figure 5E). These T cells also had increases in
DNA damage foci (γH2AX/53BP1 co-localization), as measured
by confocal microscopy (Figure 5F). It is well-known that
the Ku70 and Ku80 heterodimer binds to DSB ends and is
required for NHEJ-mediated DNA repair. It is also required
for V(D)J recombination, which utilizes the NHEJ pathway to
promote antigen diversity in the mammalian immune system.
In addition to its role in NHEJ, Ku is also involved in telomere
maintenance (42). It has been reported that mutant mice with
deficient Ku70 exhibit premature aging (43), suggesting that
Ku70 plays an important role in longevity assurance and that
reduced ability to repair DSB or maintain telomere integrity
causes premature aging. To determine the role of ATM in Ku70mediated telomeric DNA damage repair, we measured the Ku70dependent, damaged telomere-induced foci (TIF) in CD4 T cells
exposed to ATMi for 48 h using confocal microscopy. As shown
in Figure 5G, Ku70/TRF1-formed TIFs were markedly increased
in cells treated with the ATMi compared to the DMSO-treated
control. We also examined the possible involvement of the
ATM pathway in homologous recombination (HR) of DNA
during DSB repair. Since RAD51 is involved in the search for
homology and strand pairing process (44, 45), we used confocal
microscopy analysis for the RAD51/TRF1-dependent TIF in
CD4 T cells exposed to ATMi or DMSO for 48 h, but found
no significant difference in TIFs between the two treatments
(Figure 5H). These results suggest that the NHEJ pathway, rather
than the HR pathway is involved in ATM-mediated telomeric
DNA repair.
Next, we examined the role of ATM in protecting T cells
from cell apoptosis and cellular dysfunction. We found that ATM
inhibition in CD4 T cells increased T cell apoptotic death and
that HIV T cells appeared to be more vulnerable to the ATMimediated apoptosis, as evidenced by the significantly higher
baseline and the level of increases in Av staining (Figure 5I)
as well as active caspase-3 levels (Figure 5J) in CD4 T cells
derived from HIV patients vs. HS. Meanwhile, these ATMitreated CD4 T cells exhibited diminished IL-2 (Figure 5K)

The ATM signaling pathway is pivotal to the maintenance of
genome integrity and cell survival (40, 41). To determine the role
of ATM in T cell function and survival, we performed siRNAmediated knockdown in healthy CD4 T cells, and then measured
cell apoptosis and cytokine expression. As shown in Figure 5A,
healthy CD4 T cells transfected with siRNA specific to ATM
(siATM) exhibited a significant decrease in ATM and pATM
protein levels compared to those treated with control siRNAs
(siCON). Concurrently, CHK2 and pCHK2 expressions were also
diminished in ATM-silenced T cells. In addition, the frequencies
of Av+ and active caspase-3+ apoptotic cells were markedly
increased, whereas the number of IFN-γ-producing CD4 T cells
was significantly decreased (Figure 5B) after ATM knockdown.
To further investigate the role of ATM in maintaining T cell
survival and function, primary CD4 T cells isolated from HS
were treated with a specific ATM inhibitor (ATMi, KU60019)
for 48 h, followed by measuring expression and activation of the
ATM/CHK2 pathway and cell apoptosis. As shown in Figure 5C,
healthy CD4 T cells exposed to KU60019 had a marked decrease
in the expression of ATM, and in particular, pATM, compared
to the DMSO-treated control. Concurrently, the levels of ATM
downstream signaling molecule CHK2, and particularly pCHK2,
were significantly suppressed by this treatment. In addition,
T cells exposed to the ATMi exhibited an elevated level of
cleaved PARP-1, indicating increased caspase 3-dependent, DNA
damage-mediated cell apoptosis.
ATM belongs to the phosphoinositide 3-kinase (PI3K) family
and plays a key role in cell survival and function (40, 41). We
thus examined whether the expression and activation of AKT
(also known as protein kinase B) could be suppressed by the
ATM inhibition. As shown in Figure 5C, both AKT and pAKT
were inhibited in CD4 T cells exposed to the KU60019 treatment.
In parallel, we also examined whether ATM expression and
activation could be blocked by the PI3K inhibitor (PI3Ki). To
this end, we incubated CD4 T cells with or without the PI3Ki
(LY294002) for 48 h and measured ATM/pATM, CHK2/pCHK2,
AKT/pAKT, as well as cleaved PARP-1 expressions by western
blot. As shown in Figure 5D, compared to the DMSO control,
T cells treated with 20 µM of LY294002 exhibited significantly
Frontiers in Immunology | www.frontiersin.org
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FIGURE 4 | DNA damage repair ATM signaling pathway in T cells of HIV patients vs. HS. (A) MRE11, RAD50, and NBN mRNA expression, as determined by real-time
RT-PCR, in CD4 T cells isolated from 8 latently HIV-infected patients and 8 age-matched HS. (B) Western blot showing MRN protein expression in CD4 T cells derived
from 8 HIV patients and 8 HS. Representative images and summary data are shown. (C) ATM mRNA levels, determined by RT-PCR, in CD4 T cells isolated from 8 HIV
patients and 8 HS. (D) Western blot analysis of ATM protein expression and phosphorylation in CD4 T cells derived from 16 HIV patients and 16 HS. Representative
images and summary data are shown. (E) Flow cytometry analysis of pATM expression in total, naïve and memory CD4 T cells from 16 HIV patients and 16 HS. (F)
CHEK2 and TP53 mRNA levels, measured by RT-PCR, in CD4 T cells from 9 HIV patients and 9 HS. (G) Flow cytometry analysis of pCHK2 expression in CD4 T cells
from 8 HIV patients and 8 HS. (H) Western blot analysis of CHK2 (n = 16), p53 (n = 7), and cleaved PARP-1 (n = 12) levels in CD4 T cells derived from HIV patients
and HS. Representative images and summary data are shown.

dysfunction, all of which potentially contribute to the CD4 T
cell loss and poor immune responses that are observed in latent
HIV infection.

and IFN-γ expressions (Figure 5L) compared to the controls.
Taken together, these results demonstrate that ATM inhibition
can lead to increased DNA damage, cell apoptosis, and cell
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FIGURE 5 | ATM plays a key role in protecting T cells from DNA damage, cell apoptosis, and cellular dysfunction. (A) Western blot analysis of ATM, pATM, CHK2, and
pCHK2 expressions in CD4 T cells transfected with ATM siRNA (siATM) or control siRNA (siCON). Representative images from repeated experiments are shown. (B)
Apoptosis and functional assays of CD4 T cells after ATM knockdown. Representative dot plots and summary of the percentage of Av (n = 7), caspase-3 (n = 7), and
IFN-γ (n = 4) expressions in CD4 T cells transfected with siATM or siCON. (C) Western blot analysis of ATM, pATM, CHK2, pCHK2, cleaved PARP-1, AKT, and pAKT
expressions in CD4 T cells treated with the ATM inhibitor (KU60019) or DMSO for 48 h. (D) Western blot analysis of ATM, pATM, CHK2, pCHK2, AKT, pAKT, and
cleaved PARP-1 expressions in CD4 T cells treated with the PI3K inhibitor (LY294002) or DMSO for 48 h. Representative images from repeated experiments are
shown. (E) Flow cytometry analysis for the MFI of γH2AX expression in CD4 T cells treated with KU60019 or DMSO for 48 h (n = 8). (F–H) Representative images of
confocal microscopy examination of co-localization of 53BP1 and γH2AX, Ku70 and TRF1, RAD51 and TRF1, in CD4 T cells treated with KU60019 or DMSO for 48 h
(n = 6). (I,J) Flow cytometry analysis of Av% and caspase-3% in CD4 T cells from HIV and HS exposed to KU60019 or DMSO for 48 h (n = 4). (K,L) Summary data of
IL-2 and IFN-γ productions in healthy CD4 T cells stimulated with PMA plus ionomycin and blocked with brefeldin A for the last 5 h in the presence of KU60019 or
DMSO for 48 h (n = 6).

Ectopic Expression of ATM in HIV CD4 T
Cells Reduces DNA Damage, Cell Death,
and Cellular Dysfunctions

survival, and cell function by assessing cleaved PARP-1, caspase3, γH2AX, IL-2, and IFN-γ expressions as readouts. Specifically,
the caspase-3-dependent cleavage of PARP-1 was decreased
in T cells transfected with the wild-type ATM, but not with
the ATM kinase-dead mutant (Figure 6C). Concurrently, the
level of the active form of caspase-3 was reduced in T cells
with ATM reconstitution, but not with the ATM-S1981A
transfection, though such decrease was not significant (data not
shown). Compared to the mock transfection, overexpression
of ATM significantly reduced γH2AX level in transfected
(His+ ) CD4 T cells, whereas transfection of the ATM-S1981A
mutant did not elicit such an effect, indicating that the ATM
kinase activity is important for protecting cells from excessive
DNA damage (Figure 6D). These results are in line with the
data showing that expression of wild-type ATM significantly
reduced cleaved PARP-1, whereas mock- or ATM-S1981Atransfected cells exhibited relatively higher levels of cleaved
PARP-1 (Figure 6C). These results suggest that ectopic ATM
expression exerts immediate effects on repairing DNA damage
and regulating T cell fate to secure cell survival. Importantly, the

Given the critical role of ATM in repairing DNA damage, we
hypothesized that the ectopic ATM could recover HIV T cells
from DNA damage and restore the signaling network required
for repairing DNA-DSB. To test this, we transfected CD4 T
cells derived from HIV-infected, cART-controlled individuals
with Flag-His-ATM expression construct or control plasmids; an
empty vector without ATM insert (Mock), and an ATM kinasedead mutant (ATM-S1981A) in which the serine residue at 1981
was substituted by an alanine residue. As shown in Figure 6A,
western blot analysis confirmed the increases in ATM and pATM
expressions in the ATM-transfected T cells compared to the
control. Additionally, protein expression and phosphorylation
(pCHK2) of the ATM downstream signaling molecule CHK2
were increased in ATM-transfected cells (Figure 6B). Although
ectopic overexpression of ATM could have broad biological
effects, we focused our investigation on DNA repair, cell
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in telomere damage and T cell senescence, as telomerase has
been shown to be inhibited by some NRTIs) (48), as well as
other comorbidities including malignancies, personal stresses,
or social and environmental factors (49–52). In addition to
central memory CD4 T cells, several groups have reported that
T stem cell memory (TSCM ) cells harbor HIV-1 provirus and are
relatively “spared” from depletion as compared to other CD4 T
cells (53, 54). Since TSCM cells fall under the naïve population
(CD45RA+ ), and this minor subpopulation is characterized by
its resistance to apoptosis, increased proliferation, and lower ROS
levels, skewing TSCM cell activation and/or differentiation into
TCM /TEM /TTE CD4 T cells might partly help to explain why T cell
senescence is increased in the absence of active HIV replication.
Since CD4 T cells from cART-controlled, latent HIV infection
are mostly uninfected and have an extremely low number of cells
harboring provirus (only 1–2 cells have HIV-1 per million of
CD4+ T cells) (55), the observed results suggest overall cellular
senescence is more likely related to cell exhaustion associated
with increased immune activation and over-proliferation driven
by chronic inflammation during HIV latency. As such, the
cellular clock that determines the number of cell divisions is
constantly turned “on,” causing critical telomere shortening and
eventually inhibiting further cell divisions. As demonstrated in
this study, ROS generated within the cellular milieu during viral
infection might also drive inflammaging. Thus, the observed
effects are likely related to chronic inflammation, rather than the
HIV reservoir itself, and such cellular exhaustion or senescence
could also apply to other chronic infections, inflammatory
diseases, and cancers. Interestingly, this residual chronic,
low-grade inflammation-mediated inflammaging during latent
HIV infection appears to trigger immune activation that may
increase the risk of developing comorbidities, similar to those
observed in the elderly. For example, individuals living with
HIV have accentuated risks for age-associated comorbidities:
a two-fold higher risk of cardiovascular disease, a three-fold
increased risk of fracture, and a risk of developing kidney
disease that is comparable to those with diabetes (8). Some
comorbidities may present at younger ages compared to the
general population, suggesting accelerated, premature aging in
the setting of well-controlled but latent HIV infection (56).
An important question is why and how CD4 T cells
accumulate DNA damage and fail to repair telomere defects
during HIV infection? Human CD4 T cells have a relatively
long-life span (∼150–160 days) and thus are exposed to a
multitude of genotoxic stresses, leading to ∼1% out of a pool
of 300 billion T cells being replaced daily (26). To maintain
genomic stability and cell survival, cells continuously recognize
and respond to DNA damage either via activation of DNA
damage checkpoints to arrest cell cycle progression and allow for
repair or, if the damaged DNA is beyond repair, by promoting
apoptosis. Notably, a major sensor of DSB is the MRN complex,
which subsequently recruits the protein kinase ATM, an enzyme
critically involved in repairing DNA damage for cell survival
(40, 41). Our results revealed that while the MRN complex was
intact, ATM was dramatically affected by HIV, even in the setting
of a robust viral suppression, and was associated with significant
DNA damage at telomeres. Accumulation of damaged DNA

reconstitution of ATM restored T cell function, as demonstrated
by the significant increase in IL-2 (Figure 6E) and the partial
recovery of IFN-γ expression (Figure 6F) in ATM-transfected
cells, whereas ATM-S1981A transfection could not induce such
an effect. Taken together, these results demonstrate that restoring
an adequate wild-type ATM level in CD4 T cells during cARTcontrolled, latent HIV infection is necessary and sufficient to
reduce the DNA damage, cell death, and cell dysfunctions.

DISCUSSION
T cells play a pivotal role in controlling viral infection.
However, the mechanisms that dysregulate T cell functions
during viral infection, particularly in the latent phase, remain
incompletely understood. In this study, we investigated the
mechanisms that perturb T cell homeostasis, apoptosis, DNA
damage and repair machineries in CD4 T cells from patients with
cART-controlled, latent HIV infection. We found a significant
depletion of CD4 T cells, which was inversely correlated with
cell apoptosis in HIV-infected individuals on cART. Additionally,
HIV-derived CD4 T cells exhibited an accumulation of DNA
damage that extended to telomeres, leading to accelerated
telomere attrition. Mechanistically, the DNA damage sensor
MRN complex remained intact, but the expression and activation
of PI3K family member ATM and its downstream checkpoint
kinase CHK2 were significantly suppressed in HIV T cells.
Consistently, ATM/CHK2 activation and cellular functions were
impaired in primary healthy CD4 T cells following ATM silencing
or exposure to an ATM inhibitor in vitro, which recapitulated the
biological effects we observed in vivo in HIV-infected patients on
cART. Importantly, ectopic expression of ATM was essential and
sufficient to reduce the DNA damage, survival deficit, and cell
dysfunctions in HIV-derived T cells. These results demonstrate
that ATM deficiency can lead to accumulation of telomeric DNA
damage, rendering CD4 T cells prone to apoptosis in latent HIV
infection. Based on these findings, we propose a novel model
(depicted in Figure 7) in which HIV infection and/or chronic
inflammation-induced ATM deficiency drives accumulation of
telomeric DNA damage, premature T cell senescence, and
apoptosis. This aberrant and constant CD4 T cell depletion
would necessitate high homeostatic proliferation that imposes
replicative stress on naïve and particularly memory CD4 T cells,
leading to further cell senescence or apoptosis—a malicious cycle
for CD4 T cell dysregulation in latent HIV infection.
The mechanisms underlying inflammaging in cARTcontrolled, latent HIV infection remain elusive, but multiple
factors may be involved. Specifically, HIV latency in the era
of cART is characterized by the existence of viral reservoirs
that prevent HIV-1 eradication and likely drive inflammaging
(46, 47). Thus, HIV-mediated inflammaging could result from a
myriad of insults, such as viral particles or viral RNAs/proteins
released from the reservoirs, cell-secreted pro-inflammatory
cytokines, HIV-enhanced gut permeability and altered gut
microbiota or dysbiosis, frequent cytomegalovirus (CMV),
Epstein–Barr virus (EBV), hepatitis B virus (HBV), and HCV
coinfections, the cART regimen itself (NRTIs may take part
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FIGURE 6 | Ectopic expression of ATM reduces DNA damage, cell apoptosis and dysfunction of CD4 T cells from HIV patients. (A–C) Western blot analysis of
ATM/pATM (n = 5), CHK2/pCHK2 (n = 4), and cleaved PARP-1 (n = 3) expression in CD4 T cells derived from HIV-infected patients with or without ATM
overexpression. (D–F) Representative dot plots and summary data of flow cytometry analysis of γH2AX (n = 4), IL-2 (n = 5), and IFN-γ (n = 5) expressions in Mock-,
ATM-, and ATM-S1981A-transfected (His+ ) CD4 T cells derived from HIV patients. P-values were determined by paired t-tests for two groups and by one-way ANOVA
for three groups.

activates the ATM cascades, along with ataxia-telangiectasia
Rad3-related (ATR) and DNA-dependent protein kinase catalytic
subunit c (DNA-PKc), which all belong to the PI3K-related kinase
(PIKK) family and are important for DNA reprogramming and
T cell rearrangement (40, 41). Because the immune system is
in constant turnover during viral infection, with high demands
for lymphocyte replenishment to maintain the equilibrium of
the T cell compartment, insufficient activation of ATM would
be expected to affect both primed and unprimed T cells.
However, memory T cells turnover rapidly with greater DNA
damage and cell apoptosis, which could compromise the size
and survival rate of the naïve T cell repertoire. Indeed, ongoing
antigenic and/or inflammatory stimulation during chronic viral
infection induces continuous differentiation of the naïve T cells
and turnover of antigen-reactive T cells, resulting in telomere
erosion and cell senescence or apoptosis, which we observed
more prominently in memory T cells. Eventually, the majority
of the T cell pool would be comprised of antigen-expanded
T cells at the expense of naïve T cells. With the decrease
in newly generated naïve thymic T cells in adults, chronic
inflammation or infection might force the immune system to
restore equilibrium by replicating the existing naïve T cells,
thereby driving telomere shortening and senescence in naïve T
cell populations in the peripheral blood. Thus, the ability to
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generate an immune response to new antigens, such as vaccines,
would be compromised.
ATM was originally identified in individuals with
ataxia-telangiectasis (AT), an autosomal recessive disorder
that manifests with progressive ataxia, telangiectasia,
immunodeficiency,
genomic
instability,
and
cancer
predisposition (57). It is a key kinase within the DDR signaling
cascade and plays a unique role in lymphocyte biology,
as programmed DDR participates in the gene remodeling
process necessary for the formation of a highly diverse TCR
repertoire (39, 40). ATM requires an activation signal (usually
a DNA damage signal), which promotes intermolecular autophosphorylation at ATM residue at serine 1981, resulting in
the dissociation of the inactive dimer into active monomers
(58). In the current study, a mutant of S1981A rendered
ATM a dominant-negative protein and triggered distinct
DNA damage-mediated cell apoptosis and cellular dysfunction
(e.g., IL-2 inhibition), which underscored the importance
of ATM phosphorylation for its biological functions. ATM
is predominantly localized in the nucleus, and is activated
once the MRN complex senses and binds to DSB ends,
thus providing a platform for ATM recruitment and autophosphorylation (59, 60). Phosphorylation of S1981 also
stabilizes ATM at the damaged DNA sites and recruits more
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pathway can be attributed to ATM insufficiency, driven by
chronic inflammation, or oxidative stress in latent HIV infection.
Further investigations of the molecular mechanisms regulating
the post-transcriptional expression, phosphorylation, and/or
dephosphorylation of these DDR kinases will shed new light
on the cellular machinery that contributes to DNA repair and
cell homeostasis.
Notably, the DNA damage sensor MRN complex is upstream
of ATM activation. It has been shown that patients with
rheumatoid arthritis exhibit premature T cell aging with
damaged telomeres and defective activity of the DNA break
sensor MRE11A (62). The DNA repair nuclease MRE11A also
functions as a mitochondrial protector and prevents T cell
pyroptosis and tissue inflammation (63). In patients with latent
HIV infection, however, we found an intact MRN complex
in CD4 T cells. Of note, ATM was inhibited at the posttranscriptional level in these cells, which produced considerable
amounts of ROS. Interestingly, Guo et al. also reported that ATM
activation in response to ROS was independent of the MRN
complexes (64, 65). ROS-mediated ATM signaling represses
mTORC1 signaling and, therefore also inhibits cell growth and
proliferation through the activation of TSC2 (a negative regulator
of mTOR) by liver kinase B1 (LKB1) and AMP-dependent
protein kinases (AMPKs) (66). Also, ATM engagement of the
TSC2/mTORC1 signaling pathway can regulate autophagy, and
differential localization of ATM correlates with activation of
distinct downstream signaling pathways (67, 68). Likewise,
we have recently reported that T cells derived from HCV
infection also exhibit pronounced telomeric DNA damage due to
remarkably elevated ROS, with intact DNA damage sensors MRN
complex but impaired ATM/CHK2 signaling pathway (19, 20).
Investigation is underway in our laboratory to illustrate the
detailed mechanisms of ROS-mediated ATM deficiency during
latent HIV infection.
It should be pointed out that ATM, as a key kinase in
DDR, can be activated in the early phase of DNA damage, as
observed in our in vitro model, in which pATM, pCHK2, and
pAKT were upregulated, whereas their total protein levels were
downregulated in CD4 T cells following active HIV infection
(unpublished observation). These changes led to a global loss
of ATM, CHK2, and AKT, which suggests an activation and
a subsequent exhaustion or senescence process. Notably, ATM
is widely expressed in human T cells at a high level to ensure
the integrity of genomic DNA in replicating lymphocytes. Its
activation may represent the initiation of DDR, but its inhibition
and insufficiency in persistently activated T cells indicate a
deficiency in DNA repair that can promote cell exhaustion and
senescence in the setting of chronic viral infection. This notion
is also supported by our recent observations in the in vitro
stimulated T cell system in which ATM phosphorylation was
increased in the early phase (3–6 h) of T cell treatment with
KML001 (a telomere targeting drug), or CPT (a topoisomerase I
inhibitor), but decreased with longer treatment period (24–48 h),
and was associated with increases in DNA damage, cell apoptosis,
and functional impairment (31, 69).
As noted above, our data demonstrated that both ATM and
CHK2 expressions and activations were ultimately diminished,

FIGURE 7 | A working model depicting the role of HIV-induced ATM deficiency
in T cell cycle arrest, telomeric DNA damage, cell senescence, and apoptosis
during chronic viral infection. HIV infection triggers the DNA damage response
(DDR) during the early phase of infection via activation of the
MRN-ATM-CHK2/P53 signaling pathways in CD4 T cells, promoting cell cycle
arrest (through the p21/p27-regulated CDK/Cyclins) and allowing DNA
damage repair. If the infection persists and causes irreparable DNA damage,
the cell will commit suicide and undergo apoptosis. Only a very small
population of HIV reservoirs harbor provirus. However, the persistent, low
grade of antigenic and inflammatory or ROS stimulation in the setting of latent
HIV-1 infection in individuals on cART drives the majority of uninfected,
bystander T cell exhaustion (PD-1) and senescence (telomere attrition) by
inducing ATM (PI3K-like kinase) activation/exhaustion and deficiency (low
protein expression and phosphorylation). This leads to inflammaging and
diminished DNA damage repair, which results in aberrant DNA damage
(γH2AX, 53BP1 accumulation), cell apoptosis (caspase-3-dependent cleavage
of PARP-1), and thus, constant CD4 T cell depletion. Excessive CD4 T cell loss
necessitates homeostatic proliferation and imposes replicative stress on
reactive, memory CD4 T cells as well as unprimed, naïve CD4 T cells, leading
to accelerated, premature T cell aging or senescence. This working model
represents a novel molecular mechanism underlying the T cell dysfunction and
immune (vaccine) non-responsiveness seen in the setting of latent HIV
infection.

downstream effector proteins to participate in the DDR (61).
Among the multiple substrates phosphorylated by ATM is
CHK2, which is phosphorylated at residue T62 following
DSB formation and prevents the cell cycle from progressing
from the G1 to the S phase or, alternatively, leads to cell
apoptosis. Our results showed that concomitant with the ATM
deficiency, CHK2 phosphorylation was defective in CD4 T cells
during HIV infection. Moreover, siRNA-mediated silencing or
pharmacological inhibition of ATM in healthy T cells also led
to the CHK2 phosphorylation defect, which was accompanied
by dramatic DNA damage and cell apoptosis—mimicking the
biological defect we observed in HIV-derived CD4 T cells. These
results establish that in human T cells, CHK2 is a downstream
target of ATM and that the overall defect of this signaling
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Cell Isolation and Culture

along with telomeric DNA damage and cell apoptosis in the
setting of cART-controlled, latent HIV infection. HIV becomes
suppressed and inactive within infected cells or reservoirs, but
still drives the inflammatory changes in the bystander cells during
latent infection. These findings beg the question of whether it is
even feasible to avoid disruption of telomeric DDR signaling and
cellular senescence/apoptosis in the HIV-infected host without
actually targeting the repair machinery itself. Consistent with
our results and proposed concept, Rossiello et al. and Fumagalli
et al. reported that telomeric DNA damage in mammalian
cells is irreparable and occurs preferentially at telomeres in
linear genomes (70, 71). Their studies suggested a paradigm
in which cellular senescence and organismal aging resulting
from persistent DNA damage signaling and accumulated,
irreparable telomeric DNA damage could be permanent via a
shared causative mechanism; i.e., once damaged, they remain
damaged. Other data suggest that persistent DDRs may trigger
senescence-associated inflammatory cytokine secretion, and thus
may facilitate communication of a compromised state to the
surrounding cells (72). Similarly, a bystander effect could occur
in which senescent cells induce DDR in proximate cells within
the milieu via cell-cell contact and ROS generation, a notion of
senescence-induced senescence (73). These mechanisms could
certainly occur in this model of HIV-infected individuals
on cART. Importantly, latently HIV-infected cells are more
susceptible to DDR-inducing agents, and thus are vulnerable to
DDR-induced cell apoptosis (74). Sensitivity to DDR highlights
a unique vulnerability of latently infected cells, a new feature
that could potentially be exploited in developing therapeutics to
eliminate HIV reservoirs. Further studies to explore the DDR
triggers are underway in our laboratory.
In summary, the accumulation of DNA damage and failure
to repair mechanisms due to deficiency of the ATM-dependent
DNA repair machinery during chronic viral infection may
broadly impair diverse cellular functions. Counteracting ATM
deficiency may restore T cell homeostasis and competency
during chronic viral infection and prevent premature T cell
aging or immune senescence. This study reveals a novel
molecular mechanism underlying T cell aging and provides a
new strategy to develop innovative approaches to correct an
aberrant immunopathology, to avoid the untoward consequences
of immune senescence and to improve immunotherapy and
vaccine responses against human viral diseases.

Peripheral blood mononuclear cells (PBMCs) were isolated from
whole blood by Ficoll density centrifugation (GE Healthcare,
Piscataway, NJ). CD4+ T cells were isolated from PBMCs using
the CD4+ T Cell Negative Selection Kit (Miltenyi Biotec Inc.,
Auburn, CA). T cells were cultured in RPMI 1640 medium
containing 10% FBS (Atlanta Biologicals, Flowery Branch,
GA), 100 IU/ml penicillin, and 2 mM L-glutamine (Thermo
Scientific, Logan, Utah) at 37◦ C and 5% CO2 atmosphere.
Cells were harvested after day 1 or day 4 of culture for the
detection of apoptosis and DNA damage. To test the role
of ATM activation in repairing DNA damage and apoptosis,
10 µM ATM inhibitor (KU60019, Abcam, Cambridge, MA)
or DMSO were added to the cultures at day 1, and the
cells were collected after 48 h for measuring apoptosis and
DNA damage. To determine the role of the PI3K pathway
in ATM activation, purified CD4 T cells were cultured for
48 h in the presence or absence of 20 µM PI3K inhibitor
(LY294002, Sigma), followed by flow cytometry or western
blot analysis.

Flow Cytometry
For phenotypic analysis of CD4 T cells, PBMCs were stained
with CD4-FITC, CD8-PE, CD57-APC (BioLegend, San Diego,
CA), CD28-PE (Invitrogen, Carlsbad, CA), CD45RA-PerCP710,
PD1-FITC (eBioscience, San Diego, CA), or isotype control
antibodies. To quantify cell apoptosis, PBMCs were stained
with CD4-A647 and CD45RA-FITC for naïve or memory
cell populations, and then stained with Annexin V-PE and
7-AAD using BD PharmingenTM PE Annexin V Apoptosis
Detection Kit I (BD Biosciences, San Jose, CA). CD4+ T
cells were also stained for caspase-3 expression following a
protocol from CaspGLOWTM Fluorescein Active Caspase-3
Staining Kit (Invitrogen). Levels of reactive oxygen species
(ROS) in CD4 T cells were measured using the DCFDAbased Cellular ROS Detection Kit (Abcam, Cambridge,
MA) or CellROX Green ROS Detection kit (ThermoFisher
Scientific, Waltham, MA) according to manufacturer’s
protocol. For intracellular staining, the cells were fixed and
permeabilized with Foxp3 Transcription Factor Staining
Buffer Set (eBioscience), and stained with pATM (Ser1981)PE antibody (BioLegend), pCHK2 (Thr68)-PE antibody,
γH2 AX-PE (eBioscience), IL-2-PE, and IFN-γ-PE (Invitrogen).
Flow cytometry was carried out as described previously
(19, 20).

MATERIALS AND METHODS
Subjects

Flow-FISH

The study protocol was approved by the institutional review
board (IRB) of East Tennessee State University and James H.
Quillen VA Medical Center (ETSU/VA IRB, Johnson City, TN).
The study subjects were composed of two populations: 183 ARTcontrolled HIV patients and 185 age-matched HS. HIV subjects
were virologically suppressed for HIV replication with cART, as
evidenced by an undetectable level of HIV-RNA. Healthy subjects
supplied by Physicians Plasma Alliance (Gray, TN) were negative
for HBV, HCV, and HIV infection. All participants were adults
and signed an informed consent form.
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Telomere length was measured by a modified Flow-FISH method
as described previously (20). Briefly, PBMCs were stained with
CD4-A647 and fixed with Cell Fixation buffer (BioLegend) for
20 min. The cells were incubated with a telomere probe TelC
(CCCTAACCCTAACCCTAA)-FITC (0.25 µg probe/mL, PNA
Bio, Newbury Park, CA) at room temperature for 10 min in dark,
and then at 82◦ C for 10 min, room temperature overnight. The
cells were washed with post-hybridization buffer twice, and then
stained with CD45RA-perCP710 and analyzed by flow cytometry.
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using a confocal laser-scanning inverted microscope (Leica
Confocal, Model TCS sp8; Germany).

TABLE 1 | The PCR primers used in this study.
Genes to be amplified

Primer sequences

ATM

F: 5′ -TGGATCCAGCTATTTGGTTTGA-3′

ATM Silencing
Approximately, 1 × 107 CD4 T cells were isolated from HS
and transfected with 100 pmol of ATM-specific SMARTpool
siGENOME siRNAs or scrambled siRNAs (Dharmacon,
Lafayette, CO) using the Human T Nucelofector Kit and
Nucleofector I Device with program U-14 (Lonza, Allendale,
NJ). After 48 h, the cells were harvested and analyzed by flow
cytometry, western blot, and confocal microscopy.

R: 5′ -CCAAGTATGTAACCAACAATAGAAGAAGTAG-3′
MRE11

′

F: 5 -CTTGTACGACTGCGAGTGGA-3

′

R: 5′ -TTCACCCATCCCTCTTTCTG-3′
RAD50

F: 5′ -CTTGGATATGCGAGGACGAT-3′
R: 5′ -CCAGAAGCTGGAAGTTACGC-3′

NBN

F: 5′ -TTGGTTGCATGCTCTTCTTG-3′
R: 5′ -GGCTGCTTCTTGGACTCAAC-3′

CHEK2

F: 5′ -CCCAAGGCTCCTCCTCACA-3′

ATM Overexpression

R: 5′ -AGTGAGAGGACTGGCTGGAGTT-3′
TP53

′

F: 5 -TCAACAAGATGTTTTGCCAACTG-3

Purified CD4+ T cells from HIV patients were transfected with
2.5 µg of pcDNA3.1, pcDNA3.1(+)Flag-His-ATM wt or human
mutant ATM [S1981A; Addgene plasmid # 31985 or 32300, a gift
from Michael Kastan (58, 75)], using the Human T Nucleofector
Kit and Nucleofector I Device (Lonza, Allendale, NJ). After
48 h, transfection efficiency was monitored by flow cytometry to
measure the frequency of His+ cells. Ectopic ATM expression
was detected by western blot. Active caspase-3, γH2 AX, and
IL-2 expressions were assessed in the His-positive cells by
flow cytometry.

′

R: 5′ -ATGTGCTGTGACTGCTTGTAGATG-3′
GAPDH

F: 5′ -TGCACCACCAACTGCCTTAGC-3′
R: 5′ - GGCATGGACTGTGGTCATGAG-3′

RNA Isolation and Real-Time RT-PCR
Total RNA was extracted from 1 × 106 cells with PureLink
RNA Mini Kit (Invitrogen), and cDNA was synthesized using
High Capacity cDNA Reverse Transcription Kit (Applied
Biosystems, Foster City, CA) per the manufacturer’s instruction.
Quantitative RT-PCR was performed in triplicates using the
following conditions: 1 cycle at 95◦ C for 10 min, followed
by 40 cycles at 95◦ C for 15 s; 60◦ C for 60 s; and 72◦ C
for 60 s. Gene expression was normalized to GAPDH, and
values were calculated using the 2−11ct method and are
expressed as fold changes. The PCR primers are shown
in Table 1.

Statistical Analysis
The data were analyzed using Prism 7 software and are presented
as mean ± SEM or median with interquartile range, depending
on if the values pass the D’Agostino-Pearson normality or
Kolmogorov-Smirnov test. Statistical outliers were removed by
ROUT method (Q = 1%). Differences between two groups
were analyzed by independent Student’s t-test or Mann Whitney
U-test, paired T-test or Wilcoxon matched-pairs signed-rank
test. Differences among three groups were analyzed by one-way
ANOVA test. Correlations were analyzed by either Pearson’s
or Spearman’s correlation, depending on the data normal
distribution test. P < 0.05, or <0.01 were considered statistically
significant or very significant, respectively.

Western Blotting
Western blot was performed as described previously (19, 20),
using pATM (Ser1981) (D6H9), MRE11, RAD50, NBS1,
PARP-1, pAKT pCHK2 (Thr68) (C13C1), γH2AX (Cell
Signaling, Danvers, MA), and β-Actin (8H10D10) antibodies
(Cell Signaling). Appropriate horseradish peroxide-conjugated
secondary antibodies (Cell Signaling) were used, and proteins
were detected with the Amersham ECL Prime Western Blotting
Detection Reagent (GE Healthcare Bio-Sciences, Pittsburgh, PA).
The blotted membranes were stripped and re-probed with ATM
(D2E2), AKT, and CHK2 (D9C6) antibodies (Cell Signaling).
Protein bands were captured and quantified by Chemi DocTM
MP Imaging System (Bio-Rad).
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